Title: Phenotyping, Relapse, and Racism

There is an impetus for the use of emerging technologies in both assessing and improving mental health, as well as in examining complex processes like recruitment practices. In this Kaleidoscope Live! the team discuss the use of digital phenotyping for relapse in schizophrenia and the monitoring of discrimination in online recruitment.


Henson, P, D’Mello, R, Vaidyam A et al. Anomaly detection to predict relapse risk in schizophrenia. Translational Psychiatry, 2021; 11:28. https://doi.org/10.1038/s41398-020-01123-7

Hangartner, D., Kopp, D. & Siegenthaler, M. Monitoring hiring discrimination through online recruitment platforms. Nature 589, 572–576 (2021). https://doi.org/10.1038/s41586-020-03136-0

Kaleidoscope team:

  • Dr Dawn N. Albertson
    Dr Dawn N. Albertson

    Summarising Dawn’s academic trajectory is not easy but, roughly: behaviour, drugs, brains on drugs and then educating people about brains, behaviour, and drugs.

    View profile
  • Prof Sukhi S. Shergill
    Prof Sukhi S. Shergill

    A multilingual MD/PhD, Sukhi is a Professor of Psychiatry and Systems Neuroscience at the Institute of Psychiatry, Psychology, and Neuroscience at King’s College London and a Psychiatrist

    View profile
  • Derek (1)
    Dr Derek K. Tracy

    Derek is the Medical Director of West London NHS Trust, and a senior lecturer at King's College London and University College London.

    View profile
  • Dr Dan W. Joyce

    Certified genius and MD/PhD wunderkid, Dan works at the Department of Psychiatry, University of Oxford and is a Consultant Psychiatrist with Oxford Health NHS Foundation Trust. Veggie, data head, and a research purist, Dan’s signature acerbic wit brings comedy and clarity to all things complicated.

    View profile